Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 19(5): e0299696, 2024.
Article in English | MEDLINE | ID: mdl-38728335

ABSTRACT

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the COVID-19 disease, which represents a new life-threatening disaster. Regarding viral infection, many therapeutics have been investigated to alleviate the epidemiology such as vaccines and receptor decoys. However, the continuous mutating coronavirus, especially the variants of Delta and Omicron, are tended to invalidate the therapeutic biological product. Thus, it is necessary to develop molecular entities as broad-spectrum antiviral drugs. Coronavirus replication is controlled by the viral 3-chymotrypsin-like cysteine protease (3CLpro) enzyme, which is required for the virus's life cycle. In the cases of severe acute respiratory syndrome coronavirus (SARS-CoV) and middle east respiratory syndrome coronavirus (MERS-CoV), 3CLpro has been shown to be a promising therapeutic development target. Here we proposed an attention-based deep learning framework for molecular graphs and sequences, training from the BindingDB 3CLpro dataset (114,555 compounds). After construction of such model, we conducted large-scale screening the in vivo/vitro dataset (276,003 compounds) from Zinc Database and visualize the candidate compounds with attention score. geometric-based affinity prediction was employed for validation. Finally, we established a 3CLpro-specific deep learning framework, namely GraphDPI-3CL (AUROC: 0.958) achieved superior performance beyond the existing state of the art model and discovered 10 molecules with a high binding affinity of 3CLpro and superior binding mode.


Subject(s)
Antiviral Agents , COVID-19 Drug Treatment , Deep Learning , SARS-CoV-2 , SARS-CoV-2/drug effects , SARS-CoV-2/metabolism , SARS-CoV-2/genetics , Antiviral Agents/pharmacology , Antiviral Agents/therapeutic use , Humans , Coronavirus 3C Proteases/metabolism , Coronavirus 3C Proteases/antagonists & inhibitors , Protein Binding , COVID-19/virology , Molecular Docking Simulation
2.
Comput Intell Neurosci ; 2021: 6049195, 2021.
Article in English | MEDLINE | ID: mdl-34824579

ABSTRACT

Scientific risk assessment is an important guarantee for the healthy development of an enterprise. With the continuous development and maturity of machine learning technology, it has played an important role in the field of data prediction and risk assessment. This paper conducts research on the application of machine learning technology in enterprise risk assessment. According to the existing literature, this paper uses three machine learning algorithms, i.e., random forest (RF), support vector machine (SVM), and AdaBoost, to evaluate enterprise risk. In the specific implementation, the enterprise's risk assessment indexes are first established, which comprehensively describe the various risks faced by the enterprise through a number of parameters. Then, the three types of machine learning algorithms are trained based on historical data to build a risk assessment model. Finally, for a set of risk indicators obtained under current conditions, the risk index is output through the risk assessment model. In the experiment, some actual data are used to analyze and verify the method, and the results show that the proposed three types of machine learning algorithms can effectively evaluate enterprise risks.


Subject(s)
Machine Learning , Support Vector Machine , Algorithms , Risk Assessment
SELECTION OF CITATIONS
SEARCH DETAIL
...